NasdaqGS:RXRXBiotechs
Assessing Recursion Pharmaceuticals (RXRX) Valuation As Shares Lose Momentum In Recent Months
Recent performance snapshot
Recursion Pharmaceuticals (RXRX) has drawn investor attention after its share price closed at US$3.01, with the stock down about 19% over the past month and roughly 12% over the past 3 months.
See our latest analysis for Recursion Pharmaceuticals.
For context, RXRX’s 1-day share price return declined 3.22%, and the 30-day share price return is down 19.30%, while the 1-year total shareholder return has fallen 26.23%. This points to fading momentum after earlier...